Ulisse Biomed S.p.A. UBM.MI Stock
Ulisse Biomed S.p.A. Price Chart
Ulisse Biomed S.p.A. UBM.MI Financial and Trading Overview
Ulisse Biomed S.p.A. stock price | 1.41 EUR |
Previous Close | 1.88 EUR |
Open | 1.86 EUR |
Bid | 1.82 EUR x N/A |
Ask | 1.87 EUR x N/A |
Day's Range | 1.85 - 1.9 EUR |
52 Week Range | 0.97 - 3.28 EUR |
Volume | 11K EUR |
Avg. Volume | 23.43K EUR |
Market Cap | 15.12M EUR |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | 62.5 |
EPS (TTM) | 0.02 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 2.2 EUR |
UBM.MI Valuation Measures
Enterprise Value | N/A |
Trailing P/E | 62.5 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 109.215965 |
Price/Book (mrq) | 2.2482014 |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | N/A |
Trading Information
Ulisse Biomed S.p.A. Stock Price History
Beta (5Y Monthly) | N/A |
52-Week Change | 10.94% |
S&P500 52-Week Change | 20.43% |
52 Week High | 3.28 EUR |
52 Week Low | 0.97 EUR |
50-Day Moving Average | 2.01 EUR |
200-Day Moving Average | 1.59 EUR |
UBM.MI Share Statistics
Avg. Volume (3 month) | 23.43K EUR |
Avg. Daily Volume (10-Days) | 6.1K EUR |
Shares Outstanding | 8.06M |
Float | N/A |
Short Ratio | N/A |
% Held by Insiders | 15.75% |
% Held by Institutions | 1.78% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | -948.91% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -11.25% |
Return on Equity (ttm) | -19.81% |
Income Statement
Revenue (ttm) | 138.44K EUR |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | -894781 EUR |
EBITDA | -994010 EUR |
Net Income Avi to Common (ttm) | -1307745 EUR |
Diluted EPS (ttm) | 0.03 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 3.79M EUR |
Total Cash Per Share (mrq) | N/A |
Total Debt (mrq) | 7.41K EUR |
Total Debt/Equity (mrq) | 0.12 EUR |
Current Ratio (mrq) | 8.121 |
Book Value Per Share (mrq) | 0.834 |
Cash Flow Statement
Operating Cash Flow (ttm) | -970460 EUR |
Levered Free Cash Flow (ttm) | -529126 EUR |
Profile of Ulisse Biomed S.p.A.
Country | Italy |
State | UD |
City | Udine |
Address | Via Cavour, 20 |
ZIP | 33100 |
Phone | 39 04 03 75 75 40 |
Website | https://www.ulissebiomed.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Ulisse Biomed S.p.A., a healthcare biotech company, provides diagnostic platforms and products. The company through its Sagitta platform offers various tests, such as Ladymed/HPV Selfy for the detection of human papillomavirus (HPV); CoronaMelt, a diagnostic test for Sars- CoV-2; CoronaMelt Var, a diagnostic assay for the detection and genotyping of Sars-CoV-2 variants; and UlisseFaster, a reagent for the pre-treatment of biological samples. It also provides various tests and reagents for sexually transmitted diseases and HPV for oropharyngeal cancer. In addition, the company's platforms also comprise NanoHybrid, a DNA/PNA based multi-modal biomolecule platform to detect specific antibodies and protein analytes directly from serum or whole blood; and Aptavir platform to develop and produce synthetic nucleic acid molecules to limit the infectivity of pathogens. Ulisse Biomed S.p.A. was founded in 2015 and is based in Udine, Italy.
Q&A For Ulisse Biomed S.p.A. Stock
What is a current UBM.MI stock price?
Ulisse Biomed S.p.A. UBM.MI stock price today per share is 1.41 EUR.
How to purchase Ulisse Biomed S.p.A. stock?
You can buy UBM.MI shares on the Milan exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Ulisse Biomed S.p.A.?
The stock symbol or ticker of Ulisse Biomed S.p.A. is UBM.MI.
Which industry does the Ulisse Biomed S.p.A. company belong to?
The Ulisse Biomed S.p.A. industry is Biotechnology.
How many shares does Ulisse Biomed S.p.A. have in circulation?
The max supply of Ulisse Biomed S.p.A. shares is 21.8M.
What is Ulisse Biomed S.p.A. Price to Earnings Ratio (PE Ratio)?
Ulisse Biomed S.p.A. PE Ratio is 70.50000000 now.
What was Ulisse Biomed S.p.A. earnings per share over the trailing 12 months (TTM)?
Ulisse Biomed S.p.A. EPS is 0.02 EUR over the trailing 12 months.
Which sector does the Ulisse Biomed S.p.A. company belong to?
The Ulisse Biomed S.p.A. sector is Healthcare.